FPH launches F&P Evora Full – compact full-face mask

News Release
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

Fisher & Paykel Healthcare launches Evora Full – a compact full-face mask for sleep
apnea

Auckland, New Zealand, 6 October 2021 – Fisher & Paykel Healthcare Corporation Limited today
announced the launch of F&P Evora
™
Full – its latest compact full-face mask for the treatment of
obstructive sleep apnea (OSA).

“Evora Full is a minimal-contact mask designed to allow patients to move and sleep freely
without compromising performance,” said Andrew Somervell, VP Products and Technology for
Fisher & Paykel Healthcare. “It offers patients full performance in a compact size.”

The mask has a floating seal and stability wings that work together to create the next generation
of Dynamic Support Technology
™
. The compact seal floats under the nose to provide patients
with a clear line of sight, while stability wings keep the seal stable.

The Evora Full mask is supported by positive clinical trial results:

 91% of trial participants rating Evora Full as ‘stable’ or ‘very stable’
1
;
 93% found the mask to be ‘comfortable’ or ‘very comfortable’
2
; and
 96% were able to sleep in their preferred sleeping position
3
.

F&P Evora Full will initially be available in Australia and New Zealand and will be launched in
other countries upon receiving clearances.

The mask comes with three seal sizes (Extra Small, Small to Medium, and Large) and two
headgear sizes (Standard and Extra Large).

For more information, visit www.fphcare.com/evorafull.

References
1. 40 out of 44 participants rated the Evora Full mask’s stability as either “very stable” or “stable.” Internal validation trial conducted by Fisher &
Paykel Healthcare on 44 participants in New Zealand. 2020.
2. 41 out of 44 participants rated the overall comfort of the Evora Full mask as “comfortable” or “very comfortable”. Internal validation trial
conducted by Fisher & Paykel Healthcare on 44 participants in New Zealand. 2020.
3. 42 out of 44 participants were able to sleep in their preferred sleeping position while using the Evora Full mask. Internal validation trial
conducted by Fisher & Paykel Healthcare on 44 participants in New Zealand. 2020.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and
systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive
sleep apnea. The company’s products are sold in over 120 countries worldwide. For more
information about the company, visit our website www.fphcare.com.

ENDS


Media & Investor Contacts:

Investors:
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073
Media:
Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911